Research Associate Professor The Rockefeller University New York, New York, United States
Please view the 2023 RPTH State-of-the-Art Illustrated Capsules here.
Learning Objectives:
Upon completion, participants will be able to list numerous vascular deficiencies that are often observed in Alzheimer's disease patients.
Upon completion, participants will be able to discuss how the Alzheimer's disease pathological peptide beta-amyloid can activate the plasma contact system to induce thrombosis and inflammatory activity.
Upon completion, participants will be able to describe why blocking the cleavage of high molecular weight kininogen could be a therapeutic strategy for Alzheimer's disease and other contact system disorders.
